Compounds > glycyrrhizic acid
Page last updated: 2024-08-21

glycyrrhizic acid and Angiogenesis, Pathologic

glycyrrhizic acid has been researched along with Angiogenesis, Pathologic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Dai, W; Guan, XY; Kam, NW; Khanna, R; Kwong, DL; Law, S; Lee, VHF; Lo, AWI; Qin, Y; Shakya, R; Wang, Y; Wu, KC; Yan, LYC1
Chang, CC; Chuang, CL; Hou, MC; Hsu, SJ; Huang, HC; Huang, YH; Lee, FY; Pun, CK; Yen, CH1
Cai, Q; Chen, X; Harris, RC; Kon, V; Pozzi, A; Shrubsole, MJ; Xu, J; Yao, B; Yin, H; Zhang, MZ; Zheng, W1
Choi, JS; Jeong, JW; Kim, KJ; Kim, KW1
Kimura, I; Kimura, M; Kobayashi, S; Miyamoto, T1

Other Studies

5 other study(ies) available for glycyrrhizic acid and Angiogenesis, Pathologic

ArticleYear
Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma.
    Angiogenesis, 2022, Volume: 25, Issue:2

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Glycyrrhizic Acid; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Mice; Neovascularization, Pathologic; Tumor Microenvironment

2022
Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.
    International journal of molecular sciences, 2021, Jul-17, Volume: 22, Issue:14

    Topics: Animals; Anti-Inflammatory Agents; Collateral Circulation; Disease Models, Animal; Glycyrrhizic Acid; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Signal Transduction; Splanchnic Circulation; Vascular Endothelial Growth Factor Receptor-2

2021
Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans.
    The Journal of clinical investigation, 2009, Volume: 119, Issue:4

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adenocarcinoma; Adenoma; Animals; Base Sequence; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Inhibitors; Gene Silencing; Genes, APC; Glycyrrhizic Acid; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Models, Biological; Neovascularization, Pathologic; Receptors, Glucocorticoid; RNA, Small Interfering

2009
The anti-angiogenic activities of glycyrrhizic acid in tumor progression.
    Phytotherapy research : PTR, 2013, Volume: 27, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Glycyrrhizic Acid; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species

2013
Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro.
    Biological & pharmaceutical bulletin, 1995, Volume: 18, Issue:10

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Cells, Cultured; Chalcone; Glucosides; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrhizic Acid; Granuloma; Male; Mice; Mice, Inbred Strains; Microtubules; Neovascularization, Pathologic; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar

1995